oncgnostics
Key Facts
Invested since | 2012 |
Based in | Thuringia |
About the company

oncgnostics develops – based on proprietary epigenetic biomarkers – highly reliable molecular in-vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in oncology.
Do you want to
know more about this company?
oncgnostics in the news
